Trevi Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRVI and other ETFs, options, and stocks.About TRVI
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease.
TRVI Key Statistics
Stock Snapshot
As of today, Trevi Therapeutics(TRVI) shares are valued at $11.20. The company's market cap stands at 1.44B, with a P/E ratio of -32.16.
During the trading session on 2026-03-12, Trevi Therapeutics(TRVI) shares reached a daily high of $12.00 and a low of $10.79. At a current price of $11.20, the stock is +3.8% higher than the low and still -6.7% under the high.
Trading activity shows a volume of 1.01M, compared to an average daily volume of 1.41M.
The stock's 52-week range extends from a low of $4.85 to a high of $14.39.
The stock's 52-week range extends from a low of $4.85 to a high of $14.39.
Analyst ratings
100%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.